Christopher Vincent Polimeni bought $4,375 of AVX
Chief Financial Officer at AVAX ONE TECHNOLOGY LTD.. 2,500 shares at an average of $1.75, traded Nov 21, 2025, filed Feb 25, 2026.
Score components
- +22RoleCFO
- 0Trade size$4k at market
- 0Relative to holdingsHoldings up 2.4%
- +8Price context95% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -23.0%, 3m -21.5%, 6m -59.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-007987, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 18, 2025 | AGrant or award Common Shares | +105,485 | $2.37 | $250k | 105,485 | Feb 25, 2026 |
| Nov 21, 2025 | POpen-market purchase Common Shares | +2,500 | $1.75 | $4,375 | 107,985 | Feb 25, 2026 |
Related signals
Other insiders at AVAX ONE TECHNOLOGY LTD. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | AVAX ONE TECHNOLOGY LTD. | Jolie Kahn Chief Executive Officer | $6,650 4,000 shares | +2% | |
| 10Weak | AVXbuy AVAX ONE TECHNOLOGY LTD. | David Ryan Welch director | $1,424 11 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.